CRBN and Miyoshi myopathy: In line with our findings, several studies using different approaches to assessing CRBN gene expression, such as real-time PCR [15,20] or gene expression profiling [21], have demonstrated the predictive value of CRBN gene expression in MM patients treated with TD, LD or pomalidomide with dexamethasone.